1.09
前日終値:
$0.9701
開ける:
$0.96
24時間の取引高:
784.96K
Relative Volume:
4.52
時価総額:
$56.57M
収益:
$28,000
当期純損益:
$-14.36M
株価収益率:
-3.0028
EPS:
-0.363
ネットキャッシュフロー:
$-11.36M
1週間 パフォーマンス:
+31.33%
1か月 パフォーマンス:
+36.71%
6か月 パフォーマンス:
-1.80%
1年 パフォーマンス:
+123.82%
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TLPH
Talphera Inc
|
1.09 | 56.57M | 28,000 | -14.36M | -11.36M | -0.363 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2020-07-20 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | 再開されました | Credit Suisse | Outperform |
| 2019-07-10 | 再開されました | Credit Suisse | Outperform |
| 2019-04-24 | 再開されました | B. Riley FBR | Buy |
| 2019-02-15 | 開始されました | Credit Suisse | Outperform |
| 2018-10-23 | 開始されました | B. Riley FBR | Buy |
| 2017-10-13 | ダウングレード | Jefferies | Buy → Hold |
| 2017-10-13 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-07-14 | 再開されました | Jefferies | Buy |
| 2016-09-15 | 繰り返されました | ROTH Capital | Buy |
| 2016-08-05 | ダウングレード | Stifel | Buy → Hold |
| 2015-10-30 | アップグレード | Jefferies | Hold → Buy |
| 2015-10-05 | 繰り返されました | ROTH Capital | Buy |
| 2015-09-02 | 開始されました | H.C. Wainwright | Buy |
| 2015-07-10 | 再開されました | ROTH Capital | Buy |
| 2015-05-06 | 繰り返されました | Mizuho | Neutral |
| 2015-05-05 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2015-03-10 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2015-03-09 | ダウングレード | Mizuho | Buy → Neutral |
すべてを表示
Talphera Inc (TLPH) 最新ニュース
Talphera Inc (TLPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Talphera Inc (TLPH) Institutional Confidence - TradingKey
Talphera Inc (TLPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Talphera Inc (TLPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Talphera Inc (TLPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Talphera Inc (TLPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TLPH Q1 2026 Earnings: Narrowed Loss Beats Expectations, No Revenue ReportedFinal Results - newsline.com
TLPH Q1 2026 Earnings: EPS Beat on Narrower Loss; Stock Dips 3%Earnings Expansion Phase - newsline.com
TLPH Q1 2026 Earnings: EPS Beat on Narrower-Than-Expected LossHigh Growth Earnings - newsline.com
TLPH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise, Stock SlipsEarnings Quality Score - newsline.com
TLPH Assumed by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
H.C. Wainwright Maintains Talphera(TLPH.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
H.C. Wainwright initiates Talphera stock coverage with buy rating By Investing.com - Investing.com India
H.C. Wainwright initiates Talphera stock coverage with buy rating - Investing.com
Talphera Q3 2025 Earnings Preview - MSN
TLPH Q1 2026 Earnings: Narrower-than-Expected Loss Despite Minimal RevenueEarnings Per Share - newsline.com
Talphera Inc. (TLPH) Sees Modest Decline as Shares Trade Near Key Support at $0.78Liquidity Sweep - The Legal Advocate
What Does CEO Vincent Angotti's Recent Stock Purchase Signal - Kavout
Talphera Inc. (TLPH) Slides 1.95%, Nears Key Support at $0.77 Amid ConsolidationValue Stock Ideas - newsline.com
TLPH Q1 2026 Earnings: Significant EPS Beat as Pre‑Revenue Biotech Advances PipelineROA Comparison - newsline.com
Talphera Trades Around 80 Cents With Focus on Single Trial Catalyst - Bez Kabli
Talphera Inc. (TLPH) Slides 1.85% as Stock Tests Support Near $0.76Hot Stock Picks - The Legal Advocate
Talphera Inc. (TLPH) Q1 2026 Earnings: Narrower Loss Surprises Analysts as Company Advances PipelineCEO Earnings Statement - Newser
Talphera Inc. (TLPH) Edges Higher as Shares Test Key Resistance at $0.88Bollinger Expansion - Newser
TALPHERA (TLPH) CMO surrenders 4,518 shares to cover RSU tax - Stock Titan
Talphera Earnings Call Highlights NEPHRO Trial Momentum - The Globe and Mail
WestPark Capital initiates coverage of Talphera (TLPH) with buy recommendation - MSN
Talphera (TLPH) Amendment: Lytton reports 1.25M shares, 2.5% - Stock Titan
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Talphera Earnings Call Highlights Trial Momentum, Risks - TipRanks
A. G. P. Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3.5 - Moomoo
Talphera, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEF - GuruFocus
How to Value Talphera (TLPH) After Q1 2026 Earnings? EPS: Not Di - GuruFocus
Talphera (TLPH) Q1 2026 Earnings Transcript - AOL.com
TLPHNafamostat Study Enrollment Progress and Financial Update - GuruFocus
Talphera targets Niyad PMA filing in 2026 and potential approval in 2027 as NEPHRO enrollment surpasses 50% - MSN
Talphera, Inc Q1 Net Income From Continuing Operations USD -2.556 Million - TradingView
Talphera Q1 2026 Earnings Call Transcript - Benzinga
TLPH: NEPHRO study enrollment exceeds 50%, with top-line data expected in H2 2026 - TradingView
Earnings call transcript: Talphera Inc Q1 2026 highlights cash position and clinical progress - Investing.com UK
Talphera (NASDAQ: TLPH) posts Q1 2026 loss and flags going concern, Nasdaq risk - Stock Titan
Talphera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Talphera: Q1 Earnings Snapshot - kare11.com
MSN Money - MSN
Talphera Inc (TLPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):